Single-cell analysis is revolutionizing our understanding of cellular diversity and disease mechanisms. Researchers uncover critical insights in genomics, oncology, and immunology by studying individual cells, essential for developing personalized medicine and targeted therapies. Integrating advanced technologies like AI and machine learning accelerates this field's growth, driven by innovative companies leading the charge.
According to BCC Research, the global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
Here, we highlight the top 10 companies leading this field, chosen for their market share, revenue, innovation, reputation, and impact.
Annual Revenue: $64.2 billion (2024)
Overview: Merck KGaA is a global leader in life sciences, providing innovative tools and technologies for single-cell analysis and proteomics. Their comprehensive solutions support cutting-edge research in genomics, oncology, and personalized medicine. Key technologies include advanced reagents and instruments for single-cell RNA sequencing and proteomics.
Annual Revenue: $42.88 billion (2024)
Overview: Thermo Fisher Scientific offers a wide range of products and services for single-cell genomics and proteomics. Their advanced technologies, such as the Ion Torrent and Applied Biosystems platforms, enable researchers to explore cellular heterogeneity and disease mechanisms rapidly.